Background and Purpose-The purpose was to test the hypothesis that increased oxygen extraction fraction (OEF), a marker of severe hemodynamic impairment measured by positron emission tomography, is an independent risk factor for subsequent ischemic stroke in this population. Methods-Adults with idiopathic moyamoya phenomena were recruited between 2005 and 2012 for a prospective, multicenter, blindly adjudicated, longitudinal cohort study. Measurements of OEF were obtained on enrollment. Subjects were followed up for the occurrence of ipsilateral ischemic stroke at 6-month intervals. Patients were censored at the time of surgical revascularization or at last follow-up. The primary analysis was time to ischemic stroke in the territory of the occlusive vasculopathy. Results-Forty-nine subjects were followed up during a median of 3.7 years. One of 16 patients with increased OEF on enrollment had an ischemic stroke and another had an intraparenchymal hemorrhage. Three of 33 patients with normal OEF had an ischemic stroke. On a per-hemisphere basis, 21 of 79 hemispheres with moyamoya vasculopathy had increased OEF at baseline. No ischemic strokes and one hemorrhage occurred in a hemisphere with increased OEF (n=21). Sixteen patients (20 hemispheres), including 5 with increased OEF at enrollment, were censored at a mean of 5.3 months after enrollment for revascularization surgery. Conclusions-The risk of new or recurrent stroke was lower than expected. The low event rate, low prevalence of increased OEF, and potential selection bias introduced by revascularization surgery limit strong conclusions about the association of increased OEF and future stroke risk. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00629915. 
I diopathic moyamoya phenomenon is poorly understood. The natural history has not been prospectively defined. The cause is unknown. The syndrome is diagnosed by clinical and imaging criteria: idiopathic stenosis or occlusion of both distal internal carotid arteries, accompanied by characteristic hypertrophy and proliferation of the small lenticulostriate arteries. 1 These vessels may serve as collateral channels to bypass the occlusions. Patients in whom the occlusive vasculopathy is idiopathic are considered to have moyamoya disease, whereas those with known vasculopathies, such as atherosclerosis, are considered to have moyamoya phenomenon. 2, 3 In North America and Europe, moyamoya most commonly affects women in their third and fourth decade of life, and the most frequent presentation is ischemic stroke or transient ischemic attack (TIA). [4] [5] [6] [7] The risk of recurrent stroke in these patients may be as high as 10% per year. 4 One large retrospective study reported a 5-year risk of recurrent ipsilateral stroke of 65% after the first ischemic symptom and 27% after angiographic diagnosis.
Surgical revascularization is commonly advocated, because of the high stroke rates reported in these retrospective case series and the hypothesis that the mechanism of stroke is hemodynamic. 2 This hypothesis is based to a large extent on data from patients with complete atherosclerotic carotid artery occlusion. 8, 9 The presence of severe hemodynamic impairment-identified as increased oxygen extraction fraction (OEF)-is a powerful and independent predictor of subsequent stroke in patients with atherosclerotic carotid occlusion. [8] [9] [10] [11] The goal of this prospective and blindly adjudicated study was to determine whether increased OEF identified a subgroup of patients with idiopathic arterial occlusive disease and moyamoya collateral vessels at high risk for future stroke.
Methods
This study was performed at a consortium of Midwest stroke centers under local institutional review board approval. Adult patients (≥18 years of age), capable of informed consent, with unilateral or bilateral idiopathic occlusive disease of the distal internal carotid artery and proximal middle cerebral artery and moyamoya collateral vessels were recruited for the study. Exclusion criteria included the presence of any other disease that might be responsible for the occlusive vasculopathy, including atherosclerosis, neurofibromatosis, meningitis, sickle cell disease, skull base radiation therapy, and pregnancy. Patients with previous unilateral surgical revascularization procedures were included if the disease also involved the contralateral hemisphere.
On enrollment, all patients underwent a detailed neurological evaluation. Cerebral vascular events were categorized based on clinical and imaging features as TIA (symptoms lasting <24 hours in duration), ischemic stroke (symptoms lasting >24 hours without hemorrhage on imaging, intraparenchymal hemorrhage, or subarachnoid hemorrhage). Patients with ischemic or hemorrhagic events were categorized as symptomatic. Patients with other presenting symptoms, such as seizures, headaches, or no symptoms (incidental) were categorized as other. Time from the most recent event to enrollment was recorded, as was the time of first-ever symptoms. Baseline characteristics were recorded, including age, sex, hypertension, previous myocardial infarction, diabetes mellitus, smoking, and alcohol consumption. Medical records, including imaging studies (catheter angiography, computed tomography, and magnetic resonance imaging) were reviewed. The location of arterial narrowing or occlusion and the presence of moyamoya collateral vessels were recorded. Patients with unilateral moyamoya phenomenon (occlusive vasculopathy and moyamoya collaterals and contralateral occlusive disease were categorized as bilateral involvement. Those with normal contralateral vasculature were categorized as unilateral.
Positron Emission Tomography Studies
All positron emission tomography (PET) studies were performed at Washington University, St Louis, Missouri. A noncontrast magnetic resonance scan of the brain was performed to permit accurate definition of infarct location. PET studies were performed on the Siemens ECAT Exact HR+ scanner, which acquired 63 slices with 2.425 mm separation, 15 cm axial field of view, and transaxial and axial resolutions of <5.24 mm full-width half-maximum. All scans were acquired in 2D mode (septa extended) and were reconstructed using measured attenuation and scatter correction. Regional OEF was measured using O-15-labeled water (injection) and oxygen (inhalation). 12 A ratio image of the PET counts in the raw O-15-labeled water and oxygen images was normalized to a whole brain mean of 0.40. The PET counts in this image are linearly proportional to OEF except for small contributions from intravascular oxygen and recirculating labeled water. The resultant errors are small (<5%) when regional oxygen metabolism is normal as it was under these circumstances.
13

OEF Analysis
Images were reconstructed using filtered back projection and scatter correction with a ramp filter at the Nyquist frequency. All images were then filtered with a 3-dimensional Gaussian filter to a uniform resolution of 16-mm full-width half-maximum. Middle cerebral artery and cerebellar regions of interest were placed in each hemisphere using stereotactic coordinates.
14 Region placement was visually inspected for all patients, and regions were redrawn by hand to exclude areas of infarction or overlap with venous sinuses, if necessary. Ratios of middle cerebral artery territory counts to total cerebellum counts were generated for both cerebral hemispheres. OEF was considered increased if the ratio exceeded the 95% confidence limit observed in 13 normal control subjects (1.10).
14 Treating physicians and patients were blinded to the results of the PET scan.
Follow-Up
Patients were followed at 6-month intervals for the occurrence of subsequent stroke. Follow-up was done on a per-hemisphere basis until the occurrence of a primary or secondary event (in that hemisphere), censoring of that hemisphere (for surgical revascularization) or the end of the study (October 2014). Follow-up was in person or by phone at the discretion of the investigators. A standardized script was used to screen for interval stroke on phone interviews. 15 The primary end point was the occurrence of ischemic stroke in the territory of the affected vessels. Secondary end points were death and any stroke. End point determination was made by an independent, experienced physician, blinded to the PET data, based on review of clinical and imaging data.
Statistical Analysis
The planned primary statistical analysis was a comparison of the survival distribution of the time to ischemic stroke occurrence in hemispheres with moyamoya vasculopathy with increased OEF versus those with normal OEF on initial PET studies, using a log-rank test. The primary hypothesis was that increased OEF in the territory of moyamoya vasculopathy was an independent predictor of ischemic stroke. Hemispheres that underwent revascularization surgery were censored at the time of surgery. On the basis of previous studies, unpublished preliminary data, and the fact that the occlusive process was distal to the circle of Willis, we estimated that 50% of hemispheres with moyamoya vasculopathy would have increased OEF. 16 We estimated a 2-year risk of stroke for hemispheres with increased OEF of 28% versus 5% for those with normal OEF. 9 On the basis of these assumptions, and using an α of 0.05 for the logrank test, a total sample size of 50 would provide 80% power to detect a significant difference between groups. Loss to follow-up and censorship was not accounted for in the power calculations.
Comparisons of baseline stroke risk factors between groups (increased OEF versus normal OEF, end point stroke versus no stroke, and censored for revascularization versus not censored for revascularization) were performed using χ 2 , Fischer exact, or Student t tests as indicated. A Bonferroni correction was applied for multiple comparisons (0.05/number of comparisons for statistical significance).
Results
Baseline Characteristics
Fifty patients with bilateral (n=40) or unilateral (n=10) idiopathic moyamoya phenomenon were enrolled and followed up for a median duration of 3.7 years (range: 10 days to 7.1 years). One subject with bilateral moyamoya phenomenon had a fatal ischemic stroke before PET and was not included in the primary analysis. Nine of the remaining 39 patients with bilateral moyamoya had one hemisphere censored on enrollment because of a previous unilateral revascularization
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April 2017 procedure. One subject was lost to follow-up after 3 months. Baseline demographic and stroke risk factors are summarized in Table. Most patients (n=37) were women in their fourth and fifth decades. The majority presented with ischemic stroke. The majority of patients (n=44) were enrolled at the central coordinating center.
Prevalence of Increased OEF at Baseline
Sixteen patients (16/49, 33%) had increased OEF in one (11 unilateral) Increased OEF was present in 2 of the 10 patients with unilateral disease and 14 of 39 surviving patients with bilateral disease. On a per-hemisphere basis, 21 of 79 hemispheres (26.5%) with moyamoya phenomenon had increased OEF. The 79 hemispheres exclude the 9 censored for revascularization surgery at baseline, the 10 uninvolved hemispheres from the unilateral moyamoya subjects, and the 2 hemispheres from the subject that died before PET. Increased OEF was not associated with any baseline clinical variable (Table) .
Surgical Revascularization During Follow-Up (Censored)
Sixteen patients (16/49, 33%) had 20 hemispheres (20/79, 25%) censored for unilateral (n=12) or bilateral (n=4) revascularization procedures during follow-up. Fourteen of the 16 had bilateral moyamoya. Five of these subjects had increased OEF at baseline (4 unilateral increased OEF and 1 bilateral). Neither of the 2 subjects with unilateral moyamoya and revascularization surgery had increased OEF. Revascularization surgery occurred at a mean of 5.3 months after enrollment (range: 1 day to 40 months). Table  compares the baseline clinical characteristics between patients who had revascularization procedures during the follow-up period to the total cohort. Subjects that were censored for interval surgical revascularization tended to be younger, present with ischemic events, and not have a history of hypertension.
Outcome
Five subjects died, including the one mentioned above with a fatal stroke before PET (please see Tables I and II in the onlineonly Data Supplement for primary and secondary end point vignettes). Two had normal OEF: one died as a complication of unilateral revascularization surgery and another died of complications after a fall at home. Two had bilateral increased OEF: one died of lung carcinoma 27 months after enrollment and the other died 7 years after enrollment from a myocardial infarction. Five subjects had a new or recurrent ischemic stroke during the follow-up period (mean time of occurrence after enrollment 20 months; range: 3 days to 60 months). Four of the five had bilateral moyamoya disease. Three presented with ischemic stroke, 1 with TIA, and 1 with hemorrhage. One of the 5 had increased OEF. This patient (patient 5, Table I in the online-only Data Supplement) underwent a revascularization procedure for the symptomatic hemisphere (with increased OEF) a week after enrollment. The end point stroke occurred in the untreated and asymptomatic contralateral hemisphere 17 months after enrollment, however. One patient with bilateral moyamoya phenomenon died of bilateral stroke 7 days after enrollment but before the scheduled PET study (patient 9). One patient with bilateral moyamoya and unilateral increased OEF on enrollment had a recurrent intraparenchymal hemorrhage in the same location 5 years after enrollment and 6 years after the presenting hemorrhage (patient 4). None of the 10 patients with unilateral disease had a contralateral stroke. No asymptomatic patient had an ischemic or hemorrhagic stroke (n=10).
Stroke Risk and Increased OEF
No ischemic strokes occurred in a hemisphere with increased OEF at baseline (0% [0/21]; 95% confidence interval [CI] 0%-14%), 17 whereas 4 ischemic strokes occurred in a hemisphere with normal OEF (6.9% [4/58] ; 95% CI, 0.1-13.6%). One of 16 patients with increased OEF (6.3% [1/16] ; 95% CI, 0-18.5%) had an ischemic stroke in the contralateral hemisphere with normal OEF at baseline and another had an ipsilateral intracranial hemorrhage. Three of 33 patients with normal OEF had an ischemic stroke (9.1% [3/33] ; 95% CI, 0%-31%). The planned primary analysis was not performed because of these results, as well as the low incidence of end point events and low prevalence of increased OEF at enrollment.
Discussion
Because of the unexpectedly low event rate and the low prevalence of increased OEF, as well as the high rate of censorship for surgical revascularization observed in this study, the hypothesis that increased OEF predicts stroke risk in this population could not be adequately tested and remains a possibility. Despite this, this study provides unique and important natural history and hemodynamic data about adult patients with moyamoya phenomenon. The risk of recurrent or first-ever stroke in adult patients with idiopathic moyamoya phenomenon was much lower than previous estimates generated from retrospective studies. In addition, the prevalence of severe hemodynamic impairment was much lower than expected. This information has important implications for future studies in this area.
Increased OEF is a robust and well-validated marker of hemodynamic impairment and stroke risk. When blood flow falls because of arterial occlusive disease, the fraction of oxygen extracted from the blood as it passes through the cerebral circulation can increase from ≈40% to ≤80%. 18 This supports normal oxygen metabolism and neurological function. The phenomenon of reduced blood flow and increased OEF has been termed misery perfusion. 19 Two prospective, blindly adjudicated studies have established that increased OEF is a powerful and independent risk factor for future stroke risk in patients with atherosclerotic carotid artery occlusion.
9,10 Although a recent randomized clinical trial of surgical revascularization for patients with symptomatic atherosclerotic occlusion and increased OEF ([COSS] Carotid Occlusion Surgery Study) failed to show a benefit with surgery, this was not a failure of increased OEF to identify a high-risk group. 11 The stroke risk in COSS patients in the medical arm (22.7% 2-year risk for stroke) was higher than in the surgical arm for patients with uncomplicated surgery (9% 2-year risk after postoperative day 2), suggesting a reduction in hemodynamic stroke risk with successful revascularization. 20 Increased OEF was identified as an increase in the ratio of oxygen to water counts (normalized to the cerebellum) as compared with normal controls. This method was chosen because arterial samples for quantitative OEF measurement were not consistently available and the contralateral cerebral hemisphere could not be used as a reference normal. This count-based OEF method performed similar to absolute measurements of OEF and hemispheric ratios of OEF in a previous validation study. 14 A similar count-based method (hemispheric ratio) was used in the recent COSS.
11,12,21 The presence of increased OEF could have been underestimated as the region of interest included the entire middle cerebral artery territory. An increase in OEF in a branch of the middle cerebral artery could have been missed. Although the present study could not adequately test the hypothesis that increased OEF predicted future stroke risk in this population, the data do not support the hypothesis: most strokes occurred in patients or hemispheres without increased OEF. What is the explanation for the risk of stroke in patients with moyamoya, if it is not related to baseline hemodynamic status? Embolic factors have been implicated in this population. 6, 22, 23 Chen et al 23 followed up 54 patients with moyamoya after baseline monitoring of microembolic signals by transcranial Doppler. Eleven of the 54 patients had microembolic signals, and microembolic signals were strongly associated with recent past ischemic events and the risk for future events. Seven of the 54 patients had an ischemic stroke during a median follow-up of 384 days. Another possible explanation is that hemodynamic impairment is temporally or regionally dynamic in this population. Some of the patients with late stroke may have developed hemodynamic impairment over time. A longitudinal study of changes in hemodynamics over time in this population would be useful. Hemodynamic status may improve over time in patients with atherosclerotic disease. 8, 24 Finally, these data from the present study indicate that a much larger study would be required to test the hemodynamic hypothesis, with longitudinal hemodynamic assessment as well.
What accounts for the low rate of stroke observed in the present study, relative to previous reports? Most previous estimates of stroke risk in adult patients with moyamoya syndrome have been generated from retrospective case series. Hallemeier et al 5 identified 34 adult patients with moyamoya syndrome and reported a 5-year risk of recurrent ipsilateral stroke of 65% after the first ischemic symptom and 27% after angiographic diagnosis. Chiu et al 4 found a 20% 5-year risk for stroke in a smaller cohort. It is possible that selection bias was present in recruitment for this study. Patients with more rapidly progressive symptoms may have been referred for revascularization surgery rather than enrolled in this study. Screening logs were not kept at enrolling sites.
Conclusions about the low stroke rate must be tempered by the number of subjects censored for revascularization surgery. This may have reduced the overall stroke rate in the cohort. Decisions for surgery were made based on clinical factors, blind to OEF results, and patient and physician preference. Reasons for surgery were not recorded. The results indicate that this blinding was successful: of the 16 patients censored for revascularization surgery, only 4 had increased OEF on enrollment. Clinical factors likely played a role in this decision, however, as there was a trend for surgery for younger patients (P=0.065), presenting with ischemic symptoms (P=0.05) and with no reported history of hypertension (P=0.02; Table) . Revascularization surgery may have altered the natural history (stroke risk) on the ipsilateral hemisphere, and it is possible that improved collateral flow may have had an impact on stroke risk in the untreated contralateral hemisphere. 25 Another limitation of this study is the lack of information on medical management of patients with moyamoya phenomenon.
The protocol did not guide medical management, and medications history was not recorded on follow-up. Finally, it should be noted that the mean age of the high OEF group was 4 years younger than those with normal OEF. Younger patients may have a lower risk of stroke, and this may have contributed to the results of the study because we were unable to control for baseline differences between groups in our analyses.
Four patients presented with primary intraparenchymal hemorrhage. One had increased OEF and had a recurrent hemorrhage 5 years after enrollment. Another had a fatal bilateral ischemic stroke days after enrollment. The role of revascularization surgery for the prevention of recurrent hemorrhage remains unclear. A recent randomized trial, The Japanese Adult Moyamoya trial, demonstrated a reduction in the risk of recurrent hemorrhage. 26 The overall impact on outcome is not clear, however. 27 Finally, patients presenting with ischemic or hemorrhagic events may be at higher risk for future stroke compared with those with other presentations. The 5 subjects with end point events presented with either ischemic symptoms (ischemic stroke in 3 and TIA in one) or hemorrhage (one subject). None of the 10 patients without ischemic or hemorrhagic presentation had a clinical end point, and only 1 underwent surgical revascularization. Similar findings were reported in the retrospective study of Hallemeier et al, 5 where none of the 3 patients with incidentally discovered moyamoya phenomenon had an ischemic or hemorrhagic event during follow-up.
It is interesting to note that none of the 10 patients with unilateral moyamoya phenomenon developed contralateral symptoms during the course of follow-up. Two underwent revascularization surgery. A recent retrospective review of 109 patients with unilateral moyamoya disease reported contralateral progression in 18, but nearly all had some arterial abnormality (eg, stenosis) present at presentation. 28 The development of contralateral disease certainly may occur, but likely at a low rate, particularly if the contralateral circulation is angiographically normal.
In conclusion, the overall risk for stroke in this cohort was lower than previous estimates. However, firm conclusions about the actual natural history rate are limited by the number of patients that were censored for revascularization surgery. In addition, the prevalence of hemodynamic impairment was much lower than expected: most patients with moyamoya phenomenon have normal OEF. Hemodynamic factors may play a role in stroke risk in this population, but larger studies will be required to test this hypothesis. Finally, patients presenting with ischemic or hemorrhagic events may be at the highest risk for future stroke.
